These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19182582)

  • 1. Temporary remission of a multirecurrent cystosarcoma phyllodes of the breast by using continuous chemotherapy.
    Di Benedetto G; Sperti V; Grassetti L; Forlini W; Scalise A; Bertani A
    Plast Reconstr Surg; 2009 Feb; 123(2):72e-73e. PubMed ID: 19182582
    [No Abstract]   [Full Text] [Related]  

  • 2. Cystosarcoma phyllodes malignum: a case report of a successive triple modality treatment.
    Paulsen F; Belka C; Gromoll C; Hehr T; Friedel G; Wolf H; Budach W; Bamberg M
    Int J Hyperthermia; 2000; 16(4):319-24. PubMed ID: 10949128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phyllodes tumors of the breast.
    Khan SA; Badve S
    Curr Treat Options Oncol; 2001 Apr; 2(2):139-47. PubMed ID: 12057132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Radiochemotherapy in the liver metastases of cystosarcoma phyllodes].
    Riepl M; Strnad V
    Strahlenther Onkol; 1994 Nov; 170(11):668-72. PubMed ID: 7974183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ifosfamide is an active drug for chemotherapy of metastatic cystosarcoma phyllodes.
    Hawkins RE; Schofield JB; Wiltshaw E; Fisher C; McKinna JA
    Cancer; 1992 May; 69(9):2271-5. PubMed ID: 1314127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystosarcoma phyllodes. Effective therapy with cisplatin and etoposide chemotherapy.
    Burton GV; Hart LL; Leight GS; Iglehart JD; McCarty KS; Cox EB
    Cancer; 1989 Jun; 63(11):2088-92. PubMed ID: 2541882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic phyllodes tumor causing small-bowel obstruction.
    Kelly RJ; Barrett C; Swan N; McDermott R
    Clin Breast Cancer; 2009 Aug; 9(3):193-5. PubMed ID: 19661046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of ifosfamide plus mesna as first-line chemotherapy in women with metastatic breast cancer.
    Ingle JN; Krook JE; Mailliard JA; Hartmann LC; Wieand HS
    Am J Clin Oncol; 1995 Dec; 18(6):498-501. PubMed ID: 8526193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful Treatment of a Locally Recurrent and Metastatic Malignant Phyllodes Tumor with Accelerated Radiotherapy and Nab-Paclitaxel, Cisplatin, and Liposomal Doxorubicin Chemotherapy.
    Koukourakis IM; Zygogianni A; Kouloulias V; Koukourakis MI
    Chemotherapy; 2021; 66(3):82-86. PubMed ID: 34233328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I study of prolonged ambulatory infusion of Ifosfamide with oral mesna.
    Olver I; Keefe D; Myers M; Caruso D
    Chemotherapy; 2005 May; 51(2-3):142-6. PubMed ID: 15886474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II study of ifosfamide in recurrent squamous cell carcinoma of the head and neck.
    Huber MH; Lippman SM; Benner SE; Shirinian M; Dimery IW; Dunnington JS; Hong WK
    Am J Clin Oncol; 1996 Aug; 19(4):379-82. PubMed ID: 8677909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor receptors and doxorubicin plus ifosfamide/mesna in recurrent breast cancer.
    Cantwell BM; Hennessy C; Millward MJ; Lennard TW
    Lancet; 1991 Jun; 337(8754):1417. PubMed ID: 1674792
    [No Abstract]   [Full Text] [Related]  

  • 13. Unusual aggressive breast cancer: metastatic malignant phyllodes tumor.
    Singer A; Tresley J; Velazquez-Vega J; Yepes M
    J Radiol Case Rep; 2013 Feb; 7(2):24-37. PubMed ID: 23705037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infiltrating ductal carcinoma and synchronous malignant phyllodes tumour. Diagnostic and therapeutic approaches.
    Merck B; Cansado Martínez P; Pérez Ramos M; Martínez Banaclocha N; Lacueva Gómez FJ; Calpena R
    Clin Transl Oncol; 2006 Nov; 8(11):830-2. PubMed ID: 17134973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cystosarcoma phylloides of the breast. A retrospective analysis of 12 cases].
    Mallebré B; Ebert A; Perez-Cantó A; Hopp H; Opril F; Weitzel H
    Geburtshilfe Frauenheilkd; 1996 Jan; 56(1):35-40. PubMed ID: 8852784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystosarcoma phyllodes: our institutional experience.
    Joshi SC; Sharma DN; Bahadur AK; Maurya R; Kumar S; Khurana N
    Australas Radiol; 2003 Dec; 47(4):434-7. PubMed ID: 14641198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine mesna excretion after intravenous and oral dosing in ifosfamide-treated children.
    Goren MP; Epelman S; Bush DA
    Cancer Chemother Pharmacol; 2004 Sep; 54(3):237-40. PubMed ID: 15184993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful chemotherapy for cystosarcoma phyllodes in a young woman.
    Allen R; Nixon D; York M; Coleman J
    Arch Intern Med; 1985 Jun; 145(6):1127-8. PubMed ID: 2988474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of aggressive cystosarcoma phyllodes after conservative treatment of breast adenocarcinoma].
    Hulet A; Michel P; Cornut F; Hustin J
    Bull Cancer; 1985; 72(2):80-6. PubMed ID: 2988675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy with doxorubicin and dacarbazine has no effect in recurrence-free survival of malignant phyllodes tumors of the breast.
    Morales-Vásquez F; Gonzalez-Angulo AM; Broglio K; Lopez-Basave HN; Gallardo D; Hortobagyi GN; De La Garza JG
    Breast J; 2007; 13(6):551-6. PubMed ID: 17983394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.